Hot Investor Mandate: Investment Firm in Western Europe Invests Up to $10M in Promising Therapeutics Discovery/Technology Platforms and Medical Devices

28 Feb

A venture capital firm with multiple offices throughout Western Europe has raised 6 funds to date, and allocates up to €10M in equity per company. The firm’s investment focus is on fast growing high-tech companies in global technology markets such as telecommunications and IT, internet/media, nanotechnology, new materials, electronics, cleantech and life science. The firm invests in companies that are based in Europe. The firm is actively seeking new investments.

In the Life Sciences, the firm seeks to invest in early-stage therapeutic discovery/technology platform, R&D services, and medical device companies. For medical devices, the firm prefers products that are close to market commercialization. The firm is opportunistic in terms of subsectors and indications. Historically, the firm invested in proteomics, CRO, cell-based expression systems, small molecule drug discovery, cell modeling/viral vector platforms, cancer diagnostics, and drug delivery. The firm does not invest in drug development.

The firm requests a board seat in each portfolio company. The firm seeks a company with a strong management team or technical experts in the relevant technology.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: